Skip to main content
. 2017 May 11;8(7):1292–1300. doi: 10.7150/jca.17741

Table 1.

Demography data of 97 patients with NSCLC for Notch gene analysis

Patient characteristics N (%) Notch1
(mean ± SD)
p value Notch2
(mean ± SD)
p value Notch3
(mean ± SD)
p value Notch4
(mean ± SD)
p value
Age, years old
Age < 70 48 (49.5%) 0.84 ± 0.36 0.29 1.07 ± 0.50 0.62 2.83 ± 4.71 0.16 0.39 ± 0.27 0.50
Age ≥ 70 49 (50.5%) 0.75 ± 0.45 1.12 ± 0.42 1.83 ± 1.29 0.36 ± 0.23
Gender
Male 58 (59.8%) 0.83 ± 0.43 0.33 1.01 ± 0.49 0.03 2.89 ± 4.34 0.05 0.40 ± 0.28 0.16
Female 39 (40.2%) 0.74 ± 0.36 1.21 ± 0.38 1.50 ± 0.86 0.33 ±0.18
Smoking status
Never 47 (48.5%) 0.77 ± 0.41 0.50 1.21 ± 0.43 0.02 1.52 ± 0.98 0.02 0.32 ± 0.19 0.04
Ever or current smoking 50 (51.5%) 0.82 ± 0.40 0.98 ± 0.46 3.09 ± 4.61 0.42 ± 0.28
Histology
Adenocarcinoma 75 (77.3%) 0.73 ± 0.36 0.01 1.23 ± 0.42 <0.001 1.86 ± 1.48 0.03 0.34 ± 0.20 0.06
Squamous cell
carcinoma
19 (19.6%) 1.02 ± 0.47 0.64 ± 0.20 4.17 ± 7.06 0.48 ± 0.36
Others 3 (3.1%) 1.01 ± 0.73 0.54 ± 0.29 2.30 ± 1.75 0.48 ± 0.27
Disease stage
I 52 (53.6%) 0.76 ± 0.41 0.45 0.96 ± 0.37 0.002 2.64 ± 4.58 0.80 0.37 ± 0.29 0.81
II 25 (25.8%) 0.80 ± 0.37 1.15 ± 0.44 1.97 ± 1.18 0.36 ± 0.18
IIIA 18 (18.6%) 0.91 ± 0.44 1.41 ± 0.54 2.06 ± 1.35 0.43 ± 0.21
Cancer recurrence
Yes 45 (46.4%) 0.84 ± 0.42 0.36 1.22 ± 0.51 0.008 2.14 ± 1.77 0.63 0.38 ± 0.23 0.81
No 52 (53.6%) 0.76 ± 0.40 0.98 ± 0.37 2.49 ± 4.44 0.37 ± 0.26

SD: standard deviation